Fresenius Medical Care AG & Co. KGaA revised earnings guidance for the full year 2022. For the period, the company expects revenue growth: low-single-digit percentage rate compared to previous outlook growth: low-to-mid-single-digit percentage rate.

Operating income is expected to decline: around mid-teens percentage rate compared to previous outlook growth: low-to-mid-single-digit percentage rate. Net income is expected to decline: around high-teens percentage rate compared to previous outlook growth: low-to-mid-single-digit percentage rate.